ERBB2 and breast cancer: According to Xiang et al, there is no significant relation between SPRY4‐IT1 expression in BC tissues and molecular subtypes (ER/PR/HER2) of breast cancer42; however, we found a significant relation between SPRY4‐IT1 and HER‐2.